Recombinant Human Activin RIIA/ACVR2A Protein, C-His tag_天津卡梅德科技发展有限公司

Recombinant Human Activin RIIA/ACVR2A Protein, C-His tag

产品编号

KMH629

别名

活化素受体RIIA, ACVR2, ACTRII, activin A receptor type 2A

规格

20ug
50ug
100ug
200ug
1mg

DATASHEET MSDS

立即询价加入询价列表大包装定制

产品介绍

Catalog Number	KMH629
Alias	活化素受体RIIA, ACVR2, ACTRII, activin A receptor type 2A
Size	20ug, 50ug, 100ug, 200ug, 1mg
Product Description	KMH629 Recombinant Human Activin RIIA/ACVR2A Protein, C-His tag contains the human ACVR2A(Ala20-Pro134) was expressed in Mammalian cells.
Molecular Name	ACVR2A
Product Introduction	Activin RIIA/ACVR2A (KMH629) ACVR2A是活化素的受体之一，参与胚胎发育和细胞分化。
Molecular Weight	32 kDa
Expression System	HEK293F Cells
Species	Human
Concentration	联系销售经理获得最新批次的浓度
Purity	≥95%
SDS-PAGE
Purification	Affinity Purification
Uniprot ID	P27037
Storage Condition	Store the product under sterile conditions after opening at -80℃ for 12 months. Store the lyophilized powder at -20℃. Avoid repeated freeze-thaw cycles.
Formulation	PBS
Shipping Condition	This product is shipped on ice packs or dry ice.
Background	Activin A receptor, type IIA, also known as ACVR2A, is a human gene. ACVR2A is an activin type 2 receptor. This gene encodes activin A type II receptor. Activins are dimeric growth and differentiation factors which belong to the transforming growth factor-beta (TGF-beta) superfamily of structurally related signaling proteins. Activins signal through a heteromeric complex of receptor serine kinases which include at least two type I (I and IB) and two type II (II and IIB) receptors. These receptors are all transmembrane proteins, composed of a ligand-binding extracellular domain with cysteine-rich region, a transmembrane domain, and a cytoplasmic domain with predicted serine/threonine specificity.
Endotoxin	< 0.1 EU per ug
Protein Family	Other protein
Biological Activity	Measured by its ability to inhibit Activin A-induced hemoglobin expression in K562 human chronic myelogenous leukemia cells. Approximately 0.01-0.05 μg/mL of Recombinant Human (rh) Activin RIIA Fc Chimera will inhibit 50% of the biological response due to
Product Declaration	该产品仅供科研使用，不可直接用于人体或注射。